AGE - AgeX Therapeutics Inc
Previous close
11.1
0 0%
Share volume: 21,904
Last Updated: Tue 26 Mar 2024 05:00:00 AM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$11.10
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-13 | 2022-08-12 | 2022-11-10 | 2023-03-31 | 2023-05-12 | 2023-08-14 | 2023-11-14 | |
| Cash flow financing | 1.500 M | 2.000 M | 1.000 M | 1.500 M | 11.500 M | 2.000 M | 2.000 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -1.636 M | -1.746 M | -1.236 M | -1.321 M | -1.865 M | -2.019 M | -1.864 M | |
| Net income | -2.706 M | -2.618 M | -2.435 M | -2.703 M | -3.277 M | -2.669 M | -5.401 M | |
| Depreciation | 33.000 K | 33.000 K | 33.000 K | 33.000 K | 33.000 K | 32.000 K | 33.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 12.000 K | 1.000 K | 4.000 K | 6.000 K | 6.000 K | 71.000 K | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | 0.000 | -10.000 M | 0.000 | 0.000 | |
| Net Borrowings | 9.036 M | 12.011 M | 14.460 M | 15.675 M | 28.312 M | 31.667 M | 1.149 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 448.000 K | 702.000 K | 466.000 K | 645.000 K | 280.000 K | 261.000 K | 397.000 K |